Biohaven strikes $795M deal for commercial partner in epilepsynews2026-08-26T17:07:48+00:00August 26th, 2026|Endpoints News|
Sandoz launches direct-to-consumer platform with growth disorder drugnews2026-07-02T17:35:43+00:00July 2nd, 2026|Endpoints News|
EU probes Sanofi for alleged smear campaign against rival flu vaccinenews2026-06-26T15:01:34+00:00June 26th, 2026|Endpoints News|
Lilly gives hospitals deadline to comply with 340B claims data policynews2026-06-02T17:50:25+00:00June 2nd, 2026|Endpoints News|
The cost of a PRV is twice as high as it was three years ago — and it’s likely to stay that way news2026-06-01T18:58:22+00:00June 1st, 2026|Endpoints News|
Adtech company Swoop buys pharmacy startup NimbleRx news2026-05-26T10:00:55+00:00May 26th, 2026|Endpoints News|
Amgen stands by rare disease drug Tavneos amid Japan liver toxicity reportnews2026-05-18T18:21:35+00:00May 18th, 2026|Endpoints News|
Rezdiffra is exceeding Wall Street’s expectations as the MASH market takes shapenews2026-05-11T18:27:48+00:00May 11th, 2026|Endpoints News|
Amazon adds Ozempic pill to same-day prescription drug kiosksnews2026-05-07T17:15:46+00:00May 7th, 2026|Endpoints News|
Amgen, AbbVie say IRA negotiations impacted Q1 salesnews2026-05-06T19:05:40+00:00May 6th, 2026|Endpoints News|
